secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVANOS MEDICAL, INC. (AVNS)
CIK:        0001606498
Form:       8-K/A
Filed at:   2025-12-05T23:59:59+00:00
Accession:  0001606498-25-000135
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avanos eliminates CCO and GC roles; final severance includes full vesting of James's 16,300 RSUs
--------------------------------------------------------------------------------

- Company eliminated Chief Commercial Officer and General Counsel positions effective Dec 1, 2025 as part of restructuring.
- Kerr Holbrook (CCO) and Mojirade James (GC) terminated; responsibilities reallocated.
- Severance: Holbrook $1,535,417; James $1,425,665; plus COBRA, prorated bonuses, equity vesting.
- 16,300 time-based RSUs granted to James on April 22, 2025 vested fully on Dec 1, 2025.
- Unvested awards treated as retirement; time-based PRSUs pro-rata vested, performance-based vest at end.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1606498/000160649825000135/0001606498-25-000135-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1606498/000160649825000135/avns-20251021.htm
  HTML page:      https://secwatch.observer/filing/0001606498-25-000135

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer